Daval, Joname B.

HRN: 21-64-42  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2022
CEFTRIAXONE 1G (VIAL)
07/23/2022
07/30/2022
IV
1.6 Grm
Q24h
PCAP C T/C UTI
Waiting Final Action 
07/25/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
07/25/2022
08/01/2022
PO
3ml
Bid
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: